BioCentury
ARTICLE | Company News

Saniona, Upsher-Smith deal

February 8, 2016 8:00 AM UTC

Upsher-Smith’s Proximagen Ltd. subsidiary and Saniona partnered to discover small molecule therapies for CNS indications using Saniona’s ion channel technology. Proximagen will have exclusive, worldwide rights to develop and commercialize compounds identified under the deal. ...